The Net Margin of Adaptimmune Therapeutics PLC (ADAP) is -39.78%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -39.78% |
2023-12-31 | -188.90% |
2022-12-31 | -609.43% |
2021-12-31 | -2570.57% |
2020-12-31 | -3285.10% |
2019-12-31 | -12247.32% |
2018-12-31 | -160.49% |
2017-12-31 | -185.41% |
2016-12-31 | -504.08% |
2015-06-30 | -201.40% |